Do Repeat Intradetrusor Botulinum Toxin Type A Injections Yield Valuable Results? Clinical and Urodynamic Results after Five Injections in Patients with Neurogenic Detrusor Overactivity-Reference-Cited by-同舟云学术

Do Repeat Intradetrusor Botulinum Toxin Type A Injections Yield Valuable Results? Clinical and Urodynamic Results after Five Injections in Patients with Neurogenic Detrusor Overactivity

Published:2007-12 Issue:6 Volume:52 Page:1729-1735
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Reitz André,Denys Pierre,Fermanian Christophe,Schurch Brigitte,Comperat Eva,Chartier-Kastler Emmanuel

Publisher

Elsevier BV

Subject

Urology

Reference21 articles.

1. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results;Schurch;J Urol,2000

2. Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study;Schurch;J Urol,2005

3. Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes;Kalsi;Eur Urol,2006

4. Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre;Kalsi;Eur Urol,2006

5. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity;Reitz;Eur Urol,2004

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

2. Botulinum Toxin Injections in the Bladder and Urethral Sphincter;Handbook of Neurourology;2023

3. Time of onset and factors associated with delayed response post intradetrusor injection of onabotulinumtoxin a in patients with neurogenic and idiopathic overactive bladder syndrome;Urology Annals;2023

4. Botulinum Toxin Injections in the Bladder and Urethral Sphincter;Handbook of Neurourology;2023

5. Current Issues of Diagnostics and Treatment of Neurogenic Dysfunction of the Lower Urinary Tract in Spinal Cord Pathology Using Botulinum Toxin Type A;Неврология и нейрохирургия. Восточная Европа;2020-11-17